|
127 Companies |
|
139 Products |
|
139 Products |
|
89 Mechanisms of Action |
|
9 Trials |
|
1220 News |
|
| «12...13141516171819202122232425» |
- 5-fluorouracil / Generic mfg., capecitabine / Generic mfg.
HEOR: Cost-minimization Analysis of Gastric Cancer Treatments in Hong Kong (clinicaltrials.gov) - Sep 3, 2012
P=N/A, N=58, Completed, Sponsor: Vivian Wing Yan Lee
- cisplatin / Generic mfg., paclitaxel / Generic mfg., capecitabine / Generic mfg.
Enrollment open, Tumor cell, Metastases: Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer (clinicaltrials.gov) - Sep 2, 2012
P=N/A, N=100, Recruiting, Sponsor: Peking University
Active, not recruiting --> Recruiting
- Enrollment open, Metastases: A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China (clinicaltrials.gov) - Sep 2, 2012
P=N/A, N=500, Recruiting, Sponsor: Peking University
Active, not recruiting --> Recruiting Not yet recruiting --> Recruiting
- Trial completion: Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis (clinicaltrials.gov) - Sep 2, 2012
P2, N=50, Completed, Sponsor: Martin-Luther-Universit
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||||||| 5-fluorouracil / Generic mfg., cisplatin / Generic mfg., docetaxel / Generic mfg.
Trial completion, Metastases: Taxotere New Indication - Gastric Cancer Treatment Registration Trial (clinicaltrials.gov) - Aug 29, 2012
P3, N=243, Completed, Sponsor: Sanofi
Recruiting --> Completed Active, not recruiting --> Completed
- | New P4 trial: Urgent vs. Early Endoscopy in High Risk Patients With Upper Gastrointestinal Bleeding (UGIB) (clinicaltrials.gov) - Aug 28, 2012
P4, N=180, Recruiting, Sponsor: Chinese University of Hong Kong
- Trial completion: LoLiRoRe;seungho-1: Safety and Efficacy of Long Limb Roux-en Y Reconstruction (clinicaltrials.gov) - Aug 28, 2012
P=N/A, N=15, Completed, Sponsor: Gangnam Severance Hospital
Active, not recruiting --> Completed Enrolling by invitation --> Completed
- Enrollment change: Capsule Endoscopy for Hemorrhage in the Emergency Room (clinicaltrials.gov) - Aug 27, 2012
P=N/A, N=50, Enrolling by invitation, Sponsor: George Washington University
Enrolling by invitation --> Completed N=25 --> 50
- Trial termination: Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage (clinicaltrials.gov) - Aug 26, 2012
P=N/A, N=121, Terminated, Sponsor: Chinese University of Hong Kong
N=25 --> 50 Recruiting --> Terminated; Slow recruitment
- Enrollment change: Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage (clinicaltrials.gov) - Aug 26, 2012
P=N/A, N=121, Terminated, Sponsor: Chinese University of Hong Kong
Recruiting --> Terminated; Slow recruitment N=242 --> 121
- Trial completion, HEOR: Assessing Quality of Life of Patients With Stomach Cancer (clinicaltrials.gov) - Aug 23, 2012
P=N/A, N=267, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
N=242 --> 121 Active, not recruiting --> Completed
- oxaliplatin / Generic mfg., docetaxel / Generic mfg.
New P2 trial, Adverse events, Metastases: Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric Adenocarcinoma (clinicaltrials.gov) - Aug 22, 2012
P2, N=50, Completed, Sponsor: Milad Hospital
- || New P3 trial: Acupuncture for Patients With Function Dyspepsia (clinicaltrials.gov) - Aug 21, 2012
P3, N=200, Recruiting, Sponsor: Chengdu University of Traditional Chinese Medicine
- || Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
New P3 trial, Metastases: SOPP: S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer (clinicaltrials.gov) - Aug 21, 2012
P3, N=338, Recruiting, Sponsor: Min-Hee Ryu
- | New P4 trial: Empirical Rescue Therapies of Helicobacter Pylori Infection (clinicaltrials.gov) - Aug 16, 2012
P4, N=424, Completed, Sponsor: Shanghai Jiao Tong University School of Medicine
- Caprelsa (vandetanib) / Sanofi
Enrollment change, Metastases: Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer (clinicaltrials.gov) - Aug 15, 2012
P2, N=8, Terminated, Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed N=60 --> 8
- | levofloxacin / Generic mfg.
New P4 trial: Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment (clinicaltrials.gov) - Aug 15, 2012
P4, N=161, Completed, Sponsor: Shanghai Jiao Tong University School of Medicine
- | clarithromycin / Generic mfg., azithromycin / Generic mfg.
New P4 trial: Aizthromycin or Clarithromycin in H-pylori Eradication Regimen (clinicaltrials.gov) - Aug 15, 2012
P4, N=78, Completed, Sponsor: Shahid Sadoughi University of Medical Sciences and Health Services
- | clarithromycin / Generic mfg.
New P4 trial: Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori (clinicaltrials.gov) - Aug 15, 2012
P4, N=180, Completed, Sponsor: Shanghai Jiao Tong University School of Medicine
- | Trial suspension, Metastases: Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction (clinicaltrials.gov) - Aug 13, 2012
P2, N=96, Suspended, Sponsor: North Central Cancer Treatment Group
N=60 --> 8 Recruiting --> Suspended
- | New P2 trial: Diabetic Gastroparesis Efficacy/Safety Study of TZP-102 (clinicaltrials.gov) - Aug 12, 2012
P2, N=120, Terminated, Sponsor: Tranzyme, Inc.
- |||||||||| onartuzumab (RG3638) / Roche
New P3 trial, Combination therapy, Metastases: A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer (clinicaltrials.gov) - Aug 8, 2012
P3, N=800, Recruiting, Sponsor: Hoffmann-La Roche
- | erythromycin / Generic mfg.
New P2 trial: Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis (clinicaltrials.gov) - Aug 6, 2012
P2, N=114, Completed, Sponsor: The Catholic University of Korea
- Trial completion: Elental study: The Effect of Elemental Diet on Gastric Emptying (clinicaltrials.gov) - Aug 6, 2012
P=N/A, N=20, Completed, Sponsor: Showa Inan General Hospital
Recruiting --> Suspended Recruiting --> Completed
- midazolam hydrochloride / Generic mfg.
Enrollment open: Covered Versus Uncovered Self-expandable Metallic Stents for Malignant Gastric Outlet Obstruction (clinicaltrials.gov) - Aug 4, 2012
P=N/A, N=0, Recruiting, Sponsor: Samsung Medical Center
Recruiting --> Completed Not yet recruiting --> Recruiting
- HEOR, Surgery: Quality of Life After Oesophageal or Gastric Cancer Surgery (clinicaltrials.gov) - Aug 2, 2012
P=N/A, N=80, Recruiting, Sponsor: Region Skane
- mitomycin / Generic mfg., everolimus / Generic mfg.
Enrollment change, Combination therapy, Metastases: S387: Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction (clinicaltrials.gov) - Aug 1, 2012
P1, N=16, Completed, Sponsor: Krankenhaus Nordwest
Not yet recruiting --> Recruiting N=21 --> 16
- mitomycin / Generic mfg., everolimus / Generic mfg.
Trial completion, Combination therapy, Metastases: S387: Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction (clinicaltrials.gov) - Aug 1, 2012
P1, N=16, Completed, Sponsor: Krankenhaus Nordwest
N=21 --> 16 Active, not recruiting --> Completed
- Trial completion: Gastric Decompression After Sub-total Gastrectomy (clinicaltrials.gov) - Jul 31, 2012
P=N/A, N=276, Completed, Sponsor: Catholic University, Italy
Active, not recruiting --> Completed Recruiting --> Completed
- Trial initiation date: Strategies for Improving Proton Pump Inhibitors (PPIs) Prescription Associated to Non-steroidal Anti-inflammatory Drugs (NSAIDs) (clinicaltrials.gov) - Jul 30, 2012
P=N/A, N=0, Withdrawn, Sponsor: Servicio Canario de Salud
Recruiting --> Completed Initiation date: Nov 2011 --> Jan 2013
- ||| Gilotrif (afatinib) / Boehringer Ingelheim
Enrollment open: Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer. (clinicaltrials.gov) - Jul 30, 2012
P1, N=76, Recruiting, Sponsor: Boehringer Ingelheim
Initiation date: Nov 2011 --> Jan 2013 Not yet recruiting --> Recruiting
- | New P2 trial, Surgery, Compliance: Compliance to ERAS After Gastric Surgery (clinicaltrials.gov) - Jul 29, 2012
P2, N=173, Recruiting, Sponsor: Chonnam National University Hospital
- | acetylcysteine solution / Generic mfg.
New P4 trial: PRUE: Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper Endoscopy (clinicaltrials.gov) - Jul 26, 2012
P4, N=230, Completed, Sponsor: Pontificia Universidad Catolica de Chile
- |||| camicinal (GSK962040) / GSK
Enrollment open: A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying (clinicaltrials.gov) - Jul 25, 2012
P2, N=70, Recruiting, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||| Gilotrif (afatinib) / Boehringer Ingelheim
New P1 trial: Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer. (clinicaltrials.gov) - Jul 23, 2012
P1, N=76, Recruiting, Sponsor: Boehringer Ingelheim
- Leukine (sargramostim) / Partner Therap
Trial termination: S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer (clinicaltrials.gov) - Jul 19, 2012
P1, N=14, Terminated, Sponsor: Southwest Oncology Group
Not yet recruiting --> Recruiting Active, not recruiting --> Terminated; lack of accrual
- Leukine (sargramostim) / Partner Therap
Enrollment change: S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer (clinicaltrials.gov) - Jul 19, 2012
P1, N=14, Terminated, Sponsor: Southwest Oncology Group
Active, not recruiting --> Terminated; lack of accrual N=24 --> 14
- Clinical: Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients (clinicaltrials.gov) - Jul 16, 2012
P=N/A, N=150, Recruiting, Sponsor: National Cancer Center, Korea
- New P1/2 trial: Acupuncture Treatment for Gastroparesis: a Pilot Study (clinicaltrials.gov) - Jul 16, 2012
P1/2, N=20, Recruiting, Sponsor: Johns Hopkins University
- Enrollment change: Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy (clinicaltrials.gov) - Jul 15, 2012
P=N/A, N=1786, Completed, Sponsor: Shandong University
N=24 --> 14 N=1052 --> 1786
- |||||||||| Kadcyla (ado-trastuzumab emtansine) / Roche
New P3 trial, Metastases: GATSBY: A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer (clinicaltrials.gov) - Jul 15, 2012
P3, N=412, Recruiting, Sponsor: Hoffmann-La Roche
- || Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health, Norgine, ASKA Pharma
New P2/3 trial: Rifaximin for Functional Dyspepsia (clinicaltrials.gov) - Jul 15, 2012
P2/3, N=90, Recruiting, Sponsor: The University of Hong Kong
- Trial completion: Confocal Laser Endomicroscopy for the Detection of Gastric Intestinal Metaplasia: a Randomized Controlled Trial (clinicaltrials.gov) - Jul 15, 2012
P=N/A, N=168, Completed, Sponsor: Shandong University
N=1052 --> 1786 Recruiting --> Completed
- Trial completion: Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy (clinicaltrials.gov) - Jul 15, 2012
P=N/A, N=1786, Completed, Sponsor: Shandong University
Recruiting --> Completed Recruiting --> Completed
- | Trial initiation date: PRAPT: Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy (clinicaltrials.gov) - Jul 14, 2012
P3, N=194, Recruiting, Sponsor: Seoul National University Bundang Hospital
Recruiting --> Completed Initiation date: Dec 2011 --> Jul 2012
- | Enrollment change: PRAPT: Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy (clinicaltrials.gov) - Jul 14, 2012
P3, N=194, Recruiting, Sponsor: Seoul National University Bundang Hospital
Initiation date: Dec 2011 --> Jul 2012 N=80 --> 194
- | Enrollment open: PRAPT: Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy (clinicaltrials.gov) - Jul 14, 2012
P3, N=194, Recruiting, Sponsor: Seoul National University Bundang Hospital
N=80 --> 194 Not yet recruiting --> Recruiting
- Trial completion: Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder (clinicaltrials.gov) - Jul 11, 2012
P=N/A, N=115, Completed, Sponsor: Comprehensive Cancer Center of Wake Forest University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | Signifor LAR (pasireotide long acting release) / Recordati
New P2 trial: Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome (clinicaltrials.gov) - Jul 9, 2012
P2, N=43, Recruiting, Sponsor: Novartis Pharmaceuticals
- BMS-833923 / BMS
Trial initiation date, Combination therapy, Metastases: A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas (clinicaltrials.gov) - Jul 1, 2012
P1, N=39, Completed, Sponsor: Bristol-Myers Squibb
Active, not recruiting --> Completed Initiation date: Mar 1956 --> Nov 2009